Delivery Order SPE2DB22D1017-SPE2DB24FE8KX
- Not listed
- This federal contract award is for the delivery of Hydrocortisone Valerate 0.2% Ointment in 45 gram tubes. The contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 5, 2021. The contract is a Delivery Order with a Firm Fixed Price of $3,348.76 and has an Ultimate Completion Date of August 6, 2021. The contract is not associated with any set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the...
- This federal contract award is for the delivery of Hydrocortisone Valerate 0.2% Ointment, 15 grams, to the Defense Logistics Agency (DLA). The contract, valued at $1,003.73, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on May 10, 2023, with a completion date of May 11, 2023. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, valued at $1,690.11, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4556403217, a 15-gram tube of 0.2% hydrocortisone ointment. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the award date was February 28, 2022. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract, valued at $11,358.44, is for the delivery of 15 gram tubes of 0.2% hydrocortisone ointment. The contract has an ultimate completion date of March 27, 2025 and was awarded on March 26, 2025. The contract is a firm fixed price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp is the prime contractor, with no major subcontractors mentioned. This contract...
- This federal contract award, valued at $1,013.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Hydrocortisone Valerate 0.2% Ointment, a pharmaceutical product, to support military healthcare programs. The contract is a Delivery Order with a Firm Fixed Price pricing type and has a completion date of June 15, 2023. It is not designated as a set-aside contract, indicating open competition....
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,125.85 firm-fixed-price contract is for the delivery of 4556497960 - Hydrocortisone Valerate 0.2% Ointment, 45g tubes. The award has no set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which serves as a critical...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,116.30, is for the supply of 15 gram tubes of 0.2% hydrocortisone ointment. The contract is a Firm Fixed Price Delivery Order with a period of performance through July 17, 2024. The award was not set aside for any specific business type. AmerisourceBergen holds a significant Indefinite Delivery...
- This contract award is for the delivery of 45 gram tubes of 0.2% hydrocortisone ointment, with a total ceiling value of $21,075.21. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract...
- This is a delivery order under a Defense Logistics Agency (DLA) Indefinite Delivery Contract (IDC) awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 15 grams of 0.2% hydrocortisone ointment, valued at $1,737.31. The award has an ultimate completion date of January 19, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that specializes in supplying medical products to federal government agencies, particularly the...
- This federal contract award is for the delivery of Hydrocortisone Val 0.2% Ointment, 15 grams, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distributor Cencora, Inc., for a ceiling value of $2,806.26. The contract has a completion date of February 8, 2024, and is a delivery order under a Firm Fixed Price contract type. The award is associated with a larger Indefinite Delivery Contract (IDC)...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FE8KXDelivery Order
This federal contract award is for the delivery of 15 gram tubes of hydrocortisone valerate 0.2% ointment. The contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a total ceiling value of $2,939.33. The contract is a delivery order with a firm fixed price and has an ultimate completion date of November 17, 2023. There is no set-aside designation indicated for this award. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which operates under the Amerisourcebergen name. Both entities are for-profit organizations registered in the System for Award Management (SAM.gov). Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 11/16/23 |